FDA de­clines to is­sue fines for non­com­pli­ant tri­al re­port­ing

The FDA said it won’t im­pose fines or take greater en­force­ment ac­tion against clin­i­cal tri­al spon­sors when they fail to prop­er­ly re­port tri­al in­for­ma­tion to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER